Biomrieux Sa Stock Today
| BMXMF Stock | USD 103.17 7.83 7.05% |
Performance1 of 100
| Odds Of DistressLess than 10
|
BioMrieux is trading at 103.17 as of the 18th of April 2024. This is a -7.05 percent decrease since the beginning of the trading day. The stock's lowest day price was 103.17. BioMrieux has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for bioMrieux SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
bioMrieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is headquartered in Marcy lEtoile, France. The company has 118.37 M outstanding shares. More on bioMrieux SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioMrieux Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioMrieux's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioMrieux or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Wei Ding |
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
bioMrieux SA [BMXMF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioMrieux's market, we take the total number of its shares issued and multiply it by BioMrieux's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. bioMrieux SA classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 118.37 M outstanding shares.
bioMrieux SA has accumulated about 524.2 M in cash with 811.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.43.
Check BioMrieux Probability Of Bankruptcy
Ownership AllocationBioMrieux holds a total of 118.37 Million outstanding shares. bioMrieux SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.28 percent of bioMrieux SA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioMrieux Ownership Details
BioMrieux Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of BioMrieux jumping above the current price in 90 days from now is close to 99%. The bioMrieux SA probability density function shows the probability of BioMrieux pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon bioMrieux SA has a beta of -0.7217 suggesting as returns on the benchmark increase, returns on holding BioMrieux are expected to decrease at a much lower rate. During a bear market, however, bioMrieux SA is likely to outperform the market. Additionally, bioMrieux SA has an alpha of 0.0873, implying that it can generate a 0.0873 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of BioMrieux to move above the current price in 90 days from now is close to 99 (This bioMrieux SA probability density function shows the probability of BioMrieux Pink Sheet to fall within a particular range of prices over 90 days) .
bioMrieux SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BioMrieux market risk premium is the additional return an investor will receive from holding BioMrieux long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioMrieux. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BioMrieux's alpha and beta are two of the key measurements used to evaluate BioMrieux's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9166 | |||
| Semi Deviation | 1.19 | |||
| Standard Deviation | 2.05 | |||
| Variance | 4.21 |
BioMrieux Stock Against Markets
Picking the right benchmark for BioMrieux pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioMrieux pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioMrieux is critical whether you are bullish or bearish towards bioMrieux SA at a given time. Please also check how BioMrieux's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioMrieux without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
BioMrieux Corporate Directors
BioMrieux corporate directors refer to members of a BioMrieux board of directors. The board of directors generally takes responsibility for the BioMrieux's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BioMrieux's board members must vote for the resolution. The BioMrieux board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Fanny Letier | Independent Director | Profile | |
| Philippe Archinard | Director | Profile | |
| Francois Lacoste | Member of the Management Committee, Director of Immunoassay Unit | Profile | |
| Harold Boel | Independent Director | Profile |
How to buy BioMrieux Pink Sheet?
Before investing in BioMrieux, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BioMrieux. To buy BioMrieux stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of BioMrieux. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase BioMrieux stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located bioMrieux SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased bioMrieux SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as bioMrieux SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in bioMrieux SA?
The danger of trading bioMrieux SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BioMrieux is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BioMrieux. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile bioMrieux SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioMrieux SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for BioMrieux Pink Sheet analysis
When running BioMrieux's price analysis, check to measure BioMrieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioMrieux is operating at the current time. Most of BioMrieux's value examination focuses on studying past and present price action to predict the probability of BioMrieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioMrieux's price. Additionally, you may evaluate how the addition of BioMrieux to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |